The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...
The University of Chicago and healthcare investment firm Deerfield Management announced today the launch of Hyde Park Discovery, a collaboration aiming to advance the development of new medicines and ...